'The Aleppo Evil' Is Making A Comeback
- Jul 28, 2016
- 1 min read
Updated: Jan 11, 2023
When the first cases were reported in Syria 275 years ago, it was called "the Aleppo boil" or "the Aleppo evil." And for good reason: The parasitic illness spread by sand flies causes nasty skin lesions that leave victims scarred for life physically and can leave emotional scars as well.
The disease, now known as Old World cutaneous leishmaniasis, or CL, is not unique to Syria. It's found in parts of the Middle East, Africa, Asia and southern Europe, according to the Centers for Disease Control. But ever since Syria's civil war started in 2011, what had been a persistent — but relatively controlled — nuisance has turned into a full-fledged outbreak.
The focus on miltefosine for all three forms of leishmaniasis in one brand is a solid clinical anchor, especially for HCPs juggling mucosal cases. I’ve been digging into the nasal health line for adjunctive care, so check out https://zimage-ai.com
The focus on miltefosine across all three forms of leishmaniasis is a real step forward for clinicians managing complex cases. Curious how the nasal health line fits into a standard ENT workflow—checking the prescribing info for dosing specifics. https://vo3-ai.net
Interesting to see the focus on miltefosine for leishmaniasis—rare to find a dedicated resource that breaks down the cutaneous vs. visceral protocols so clearly. For anyone digging deeper into the prescribing specifics, I've been referencing https://pika-labs-ai.com
The focus on science-driven care across nasal health and barrier-friendly skincare is exactly what modern wellness needs—and the Impavido approval for leishmaniasis shows real depth. For anyone digging into the prescribing details, I’ve been referencing the full info here https://glmmodel.com
Love seeing miltefosine get its due for leishmaniasis—finally a solid option beyond the older regimens. The barrier-friendly skincare angle is a smart crossover too. I've been digging into the full prescribing info for the mucosal cases, and the dosing nuances are worth a closer look. Check out https://ai-for-animation.com